CTL responses to a DNA vaccine encoding E7 gene of human papillomavirus type 16 from an Iranian isolate

Iranian Journal of Immunology

Volumn 5, Issue 2, 2008, Pages 82-91

  Meshkat, Zahra ^a   Soleimanjahi, Hoorieh ^a   Mahmoudi, Mahmoud ^b   Hassan, Zuhair Mohammad ^a   Mirshahabi, Hessam ^a   Meshkat, Mojtaba ^c   Kheirandish, Maryam ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

DNA vaccine; E7 gene; Human papillomavirus type 16; Immune responses

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; PROTEIN E7; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; IRAN; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TUMOR CELL; UTERINE CERVIX CARCINOMA; VIRUS GENE; VIRUS ISOLATION;

EID: 45349091115     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Randall CN. Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease. Expert Opin Biol Ther. 2003; 3: 477-86
2. Chakrabarti O, Krishna S. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumor progression. J Bio Sci. 2003; 28: 337-48.
3. Comerford SA, McCance DJ, Dougan G, Tite JP. Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. J Virol. 1991; 65: 4681-90.
4. Huh KW, DeMasi J, Ogawa H, Nakatani Y, Howley PM, Munger K. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-KDa retinoblastoma protein-associated factor p600. Proc Natl Acad Sci USA. 2004; 102: 11492-7.
5. Sathish N, Abrahama P, Peedicayil A, Sridharan G, John S, Shaji RV et al. HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol. 2004; 31: 204-9.
6. Michle N, Osen W, Gissmann L, Schumacher TNM, Zentgraf H, Muller M. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virol. 2002; 294: 47-59.
7. Massa S, Franconi R, Brandi R, Muller A, Mett V, Yusibov V, Venuti A. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine. 2007 ;25:3018-21.
8. Paavonen J, Lehtinen M. Introducing human papillomavirus vaccines - questions remain. Ann Med. 2008;40:162-6.
9. Mackova J, Kutinova L, Hainz P, Krystofova J, Sroller V, Otahal P et al. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12. Int J Oncol. 2004; 24: 1581-8.
10. Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 2000; 60: 1035- 42.
11. Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M et al. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res. 2001; 61: 3698-703.
12. Trimble C, Lin CT, Hung CF, Pai S, Juang J, He L et al. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine. 2003; 21: 4036-42.
13. Smith HA, Klinman DM. The regulation of DNA vaccines. Curr Opin in Biotechnol. 2001, 12:299-303.
14. Meshkat Z, Soleimanjahi H, Mahmoudi M, Mirshahabi H, Hassan ZM, Ghaffari SR et al. Determination of human papillomavirus type 16 genotype and construction of cloning vector pTZ57R encoding HPV16 E7 gene. Saudi Med J. 2007; 28:1511-5.
15. Hung CF, Monie A, Alvarez RD, Wu TC. DNA vaccines for cervical cancer: from bench to bedside. Exp Mol Med. 2007; 39: 679-89.
16. Doorbar J. The papillomavirus life cycle. J Clin virol. 2005; 32: 7-15.
17. Brinkman JA, Xu X, Kast WM. The efficacy a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV 16 induced tumors. Vaccine. 2007; 25: 3437-44.
18. Zhang LF, Zhou J, Chen S, Cai LL, Bao QY, Zheng FY et al. HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine. 2000; 18: 1051-8.
19. Robinson HL. Nucleic acid vaccines: an overview. Vaccine. 1997; 15: 785-7.
20. Wilson CC, McKinney D, Anders M, MaWhinney S, Forster J, Crimi C et al. Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1. J Immunol. 2003; 171: 5611-23.
21. Hartigan-O'Connor D, Chamberlain JS. Developments in gene therapy for muscular dystrophy. Micros Res Tech. 2000; 48: 223-38.
22. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljeström P. Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol. 1998; 16: 562-5.